Nantkwest Inc CS (NK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NK | APLS | MRUS | ||
| Company | Nantkwest Inc CS | Apellis Pharmaceuticals Inc | Merus N.V. CS | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 30.34 | 29.40 | 51.67 | ||
| High | 33.15 | 29.94 | 53.49 | ||
| Low | 29.74 | 28.23 | 50.71 | ||
| Last | 32.49 | 28.25 | 50.93 | ||
| Change | +4.21 | -1.01 | -0.70 | ||
| % Change | +14.89% | -3.45% | -1.36% | ||
| Volume | 1,109,000 | 1,594,500 | 195,800 | ||
| 20-Day Average Volume | 1,620,320 | 3,141,875 | 353,955 | ||
| Previous Close | 28.28 | 29.26 | 51.63 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 31.51 | 28.03 | 52.19 | ||
| 20-Day Raw Stochastic | 41.94% | 63.89% | 36.01% | ||
| 20-Day Relative Strength | 58.89% | 44.38% | 47.28% | ||
| Weighted Alpha | +342.67 | -50.88 | +58.05 | ||
| Today's Opinion | 100% Buy | 80% Sell | 8% Sell | ||
| Previous Opinion | 80% Buy | 80% Sell | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.56% since 03/02/21 | -2.01% since 11/06/24 | -4.14% since 11/06/24 | ||
| Low | 23.15 on 03/05/21 | 27.73 on 11/07/24 | 50.71 on 11/13/24 | ||
| High | 33.15 on 03/09/21 | 30.46 on 11/11/24 | 55.39 on 11/07/24 | ||
| 1-Month | |||||
| %Chg | +15.79% since 02/09/21 | +4.09% since 10/11/24 | -4.63% since 10/11/24 | ||
| Low | 23.15 on 03/05/21 | 24.34 on 11/05/24 | 48.42 on 11/05/24 | ||
| High | 45.42 on 02/22/21 | 30.46 on 11/11/24 | 55.39 on 11/07/24 | ||
| 3-Month | |||||
| %Chg | +216.36% since 12/09/20 | -20.91% since 08/13/24 | -0.33% since 08/13/24 | ||
| Low | 10.00 on 12/10/20 | 24.34 on 11/05/24 | 46.65 on 09/26/24 | ||
| High | 45.42 on 02/22/21 | 41.94 on 09/09/24 | 55.39 on 11/07/24 | ||
| 6-Month | |||||
| %Chg | +393.77% since 09/09/20 | -34.32% since 05/13/24 | +11.08% since 05/13/24 | ||
| Low | 6.51 on 09/11/20 | 24.34 on 11/05/24 | 42.60 on 05/21/24 | ||
| High | 45.42 on 02/22/21 | 43.99 on 05/22/24 | 61.61 on 05/24/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,552,620 | 3,639,739 | 3,534,796 | ||
| Shares Outstanding, K | 109,345 | 124,393 | 68,464 | ||
| Annual Sales | 110,000 | 396,590,000 | 43,950,000 | ||
| Annual Net Income | -92,380,000 | -528,630,000 | -154,940,000 | ||
| Last Quarter Sales | 20,000 | 196,830,000 | 11,770,000 | ||
| Last Quarter Net Income | -32,140,000 | -57,450,000 | -99,910,000 | ||
| 60-Month Beta | 2.38 | 0.87 | 1.12 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.46 on 11/05/24 | -0.95 on 10/31/24 | ||
| Latest Earnings Date | 03/24/21 | 11/05/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||